logo
Select company
Select metric
$ -15.98MFree Cash Flow
VS
Market
25
Sector
49
Industry
34
History
41
$ 11.72Close
$ 2.43 - $ 11.92 52-Week Range
Ticker Information

Ticker

XGN

Company Name

EXAGEN INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

EXAGEN INC - Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XGN - FCF Historical data
DateCapital ExpenditureFree Cash FlowNet Cash Flow - Operations
6/30/2025$ 609K$ -15.98M$ -15.37M
3/31/2025$ 536K$ -15.45M$ -14.91M
12/31/2024$ 515K$ -13.79M$ -13.28M
9/30/2024$ 453K$ -5.75M$ -5.29M
6/30/2024$ 308K$ -6.33M$ -6.03M
3/31/2024$ 494K$ -14.25M$ -13.75M
12/31/2023$ 804K$ -15.27M$ -14.46M
9/30/2023$ 1.13M$ -29.67M$ -28.55M
6/30/2023$ 2M$ -34.32M$ -32.32M
3/31/2023$ 3.63M$ -36.95M$ -33.32M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EXAGEN INC's latest trailing twelve months (TTM) FCF stands at $ -14.59M.
  • Over the past 5 years, EXAGEN INC's average FCF has been $ -21.4M.
  • The median FCF for EXAGEN INC during this period was $ -15.93M
  • EXAGEN INC reached its highest FCF over the past 5 years at $ -5.75M.
  • The lowest FCF recorded by EXAGEN INC in the same timeframe $ -37.43M

EXAGEN INC's FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Benchmarks
CompanyFCF
CVRX : CVRX INC $ -39.43MELMD : ELECTROMED INC $ 11.13MDERM : JOURNEY MEDICAL CORP $ -2.71MLNSR : LENSAR INC $ -5.23MACRS : ACLARIS THERAPEUTICS INC $ -10.05MENTA : ENANTA PHARMACEUTICALS INC $ -43.57MMASS : 908 DEVICES INC $ -29.28MTHTX : THERATECHNOLOGIES INC $ 5.13MSGHT : SIGHT SCIENCES INC $ -22.64MPDEX : PRO DEX INC $ -2.93M

Definition of Free Cash Flow

[Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
CF - Operations - CapEx
(=) FCF
FCF for EXAGEN INC is calculated as follows: CF - Operations [ $ -14.11M ] - CapEx [ $ 476K ]
(=) FCF [ $ -14.59M ]

XGN - Free Cash Flow, Last 5 years

$ -37.43M

Minimum

Sep 30, 2022

$ -5.75M

Maximum

Sep 30, 2024

$ -21.4M

Average

$ -15.93M

Median

FCF Benchmark Analysis

The chart above depicts the distribution of FCF for companies in the Total Stock Market. The average FCF of the companies is $ 28.76M with a standard deviation of $ 117.98M.
The following table provides additional summary stats:
FCF in the Market:
filtered constituents3.3K
min$ -356.66M
max$ 390M
average$ 28.76M
median$ 461K
std$ 117.98M